Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J DeAngelo

Showing results (101-110 of 320) with videos related to

Pageof 32
Sort By:
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Blood Advances|January 4, 2018
Systematic <i>STAT3</i> sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemiaElizabeth A Morgan, Mark N Lee, Daniel J DeAngelo, et al.
The Journal of Clinical Investigation|September 7, 2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemiaPatrick D Bhola, Brenton G Mar, R Coleman Lindsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host diseaseDaniel J DeAngelo, Ephraim P Hochberg, Edwin P Alyea, et al.
Journal of Neuropathology and Experimental Neurology|July 31, 2018
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral EdemaMatthew Torre, Isaac H Solomon, Claire L Sutherland, et al.
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2017
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemiaRachael F Grace, Daniel J DeAngelo, Kristen E Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
British Journal of Haematology|August 12, 2009
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin LymphomaMichael Dickinson, David Ritchie, Daniel J DeAngelo, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assayMichael J Kluk, Ryan P Abo, Ronald D Brown, et al.
Pageof 32

Showing results (101-110 of 320) with videos related to

Sort By:
Pageof 32
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Blood Advances|January 4, 2018
Systematic <i>STAT3</i> sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemiaElizabeth A Morgan, Mark N Lee, Daniel J DeAngelo, et al.
The Journal of Clinical Investigation|September 7, 2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemiaPatrick D Bhola, Brenton G Mar, R Coleman Lindsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host diseaseDaniel J DeAngelo, Ephraim P Hochberg, Edwin P Alyea, et al.
Journal of Neuropathology and Experimental Neurology|July 31, 2018
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral EdemaMatthew Torre, Isaac H Solomon, Claire L Sutherland, et al.
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2017
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemiaRachael F Grace, Daniel J DeAngelo, Kristen E Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
British Journal of Haematology|August 12, 2009
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin LymphomaMichael Dickinson, David Ritchie, Daniel J DeAngelo, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assayMichael J Kluk, Ryan P Abo, Ronald D Brown, et al.
Pageof 32